Cerulean Pharma Announces Pricing of Initial Public

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Cerulean Pharma Announces Pricing of Initial Public Offering

CAMBRIDGE, Mass., April 10, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq: CERU ) today announced the pricing of its initial public offering of 8,500,000 shares of its common stock at a public offering price of $7.00 per share, before underwriting discounts. In addition, Cerulean has granted the underwriters a 30-day option to purchase up to an additional 1,275,000 shares of common stock at the public offering price, less underwriting discounts. Cerulean's common stock has been approved for listing on the NASDAQ Global Market and is expected to begin trading under the ticker symbol "CERU" today.

The offering is expected to close on April 15, 2014, subject to customary closing conditions.

Leerink Partners is acting as sole book-running manager for the offering. Canaccord Genuity, JMP Securities and Wedbush PacGrow Life Sciences are acting as co-managers for the offering.

A registration statement relating to the securities being sold in this offering has been filed with and declared effective by the Securities and Exchange Commission. The offering is being made only by means of a prospectus, copies of which may be obtained from Leerink Partners LLC, Attention: Syndicate Department, One Federal Street, 37th Floor, Boston, MA 02110, or by email at syndicate@leerink.com , or by phone at (800) 808‐7525, ext. 4814.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Cerulean

Cerulean Pharma Inc. is a clinical-stage oncology-focused company applying its proprietary Dynamic Tumor Targeting ™ platform to develop differentiated therapies. The Company's nanopharmaceutical product candidates consist of proprietary polymers that are covalently linked to anti-cancer therapeutics. The Company's technology platform can be also applied to a wide range of drug molecules, ranging from small molecules to peptides and RNAs. Cerulean is located in Cambridge, Massachusetts.

Media Contact: Laura Kempke MSLGROUP +1 781-684-0770

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 179

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 311

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 200

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 477

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 0

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

LanzaJet Partners with Fluor for Innovative Sustainable Aviation Fuel Project

Updated Category News Views 255

LanzaJet Collaborates with Fluor Corporation for Project Speedbird CHICAGO — LanzaJet, Inc., a frontrunner in the sustainable fuels technology sector, has announced its partnership with Fluor Corporation for the Front-End Engineering and Design (FEED) of Project Speedbird. This cutting-edge initiative will focus on developing a commercial-scale ethanol-to-sustainable...

Continue Reading
Remarkable Gains of Pippin and AB Tokens Amid Crypto Losses

Updated Category News Views 117

Understanding the Cryptocurrency Market Disruptions In a tumultuous year for large-cap cryptocurrencies, many investors found themselves disheartened by the significant declines in values. However, amidst these struggles, two lesser-known tokens made an unexpected leap, capturing the financial world's attention with stunning performances. The Unprecedented Surge of Pippin...

Continue Reading
Celebrate Spring with Unforgettable Experiences at Grande Lakes

Updated Category News Views 198

Experience the Magic of Spring at Grande Lakes Orlando The changing of seasons brings a wonderful opportunity to celebrate, and there’s no better place to embrace the spirit of spring than at Grande Lakes Orlando. Nestled within a lush landscape, this expansive resort offers a perfect blend of adventure, relaxation, and luxury. Visitors can indulge in a variety of...

Continue Reading
NASA's SpaceX Crew-9 Astronauts Share Insights from Space Mission

Updated Category News Views 365

NASA's SpaceX Crew-9 Astronauts Share Mission Insights After an extensive mission aboard the International Space Station (ISS), the NASA astronauts from the SpaceX Crew-9 will gather for a post-flight news conference. The event is set to offer a unique opportunity to delve into the rich scientific endeavors undertaken during their extraordinary stay in space. The...

Continue Reading
Essity Achieves EcoVadis Platinum Medal for Sustainability Excellence

Updated Category News Views 167

Essity Recognized for Sustainability Leadership Essity, a global leader in hygiene and health solutions, has been awarded the prestigious Platinum medal by EcoVadis for its outstanding performance in sustainability. This achievement places the company in the top 1% of all assessed companies worldwide, reflecting its dedication to responsible business practices. Strong...

Continue Reading